After successfully launching a product in its lead indication, our client continued to explore additional oncology indications to expand the blockbuster franchise. Acsel was initially engaged to evaluate the market access landscape and evidence requirements in this follow-on indication, but after the initial delivery of findings, the client retained Acsel for a broader range of key access initiatives to support the launch.
Backed by thorough research, rigorous analysis, and extensive global experience, Acsel delivered a comprehensive portfolio of launch tools:
The Acsel team provided hands-on guidance through this journey and became an integral part of our client’s launch team. From the ongoing partnership, we understood the nuances of the product’s challenges across key markets, realized synergies, and delivered with precision to successfully go to market with an expanded breadth of indications.